| | Report | Presentation | Webcast |
| November 17, 2023Presentation - Vivesto - Paccal Vet redo för nästa steg | | | |
| November 16, 2023Interim Report Q3 2023 | | | |
| October 26, 2023Interview Erik Penser Bank | | | |
| August 24, 2023Presentation - EPB Bolagsdag | | | |
| August 24, 2023Interim Report Q2 2023 | | | |
| May 25, 2023Presentation Erik Penser Bank | | | |
| May 25, 2023Interim Report Q1 2023 | | | |
| April 25, 2023Annual Report 2022 | | | |
| February 23, 2023Year-end Report 2022 | | | |
| November 17, 2022Interim Report January – September 2022 | | | |
| August 25, 2022Interim Report January – June 2022 | | | |
| May 25, 2022Interim Report January – March 2022 | | | |
| May 5, 2022Anglonordic Life Science Conference | | | |
| April 28, 2022Annual Report 2021 | | | |
| March 14, 2022Oasmia Pharmaceutical – Aktiedagen Stockholm | | | |
| January 19, 2022Rights Issue Presentation at Erik Penser Bank | | | |
| January 19, 2022Year-end Report 2021 | | | |
| December 2, 2021Presentation at Stora Aktiedagen Stockholm | | | |
| December 2, 2021Oasmia - Presentation Erik Penser Bank | | | |
| November 18, 2021Interim Report January – September 2021 | | | |
| October 21, 2021Interview Erik Penser Bank | | | |
| September 29, 2021Naventus LifeScience Summit | | | |
| September 7, 2021Presentation at Aktiedagen Stockholm | | | |
| August 19, 2021Interim Report January – June 2021 | | | |
| June 11, 2021Aktiespararna: Interview with Oasmia Pharmaceutical | | | |
| May 27, 2021Interim Report January – March 2021 | | | |
| April 29, 2021Annual Report 2020 | | | |
| April 12, 2021Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting | | | |
| March 21, 2021BioEurope Spring, Virtual | | | |
| March 11, 2021Sachs 14th Annual European Life Sciences CEO Forum, Virtual | | | |
| March 1, 2021Oasmia acquires global development and commercialization rights for Cantrixil | | | |
| February 19, 2021Year-end report 2020 | | | |
| January 19, 2021SEB Digital Healthcare Seminar Presentation | | | |
| December 9, 2020Interim Report May – October 2020 – Report | | | |
| December 3, 2020Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer | | | |
| November 11, 2020Investival Showcase 11-16 November 2020, Virtual Conference | | | |
| October 29, 2020BIO-Europe®, Virtual Conference | | | |
| October 7, 2020Oasmia Erik Penser Cancer Day Presentation | | | |
| September 24, 2020Oasmia Erik Penser Investor Event Presentation | | | |
| September 21, 2020Presentation at Sachs Biotech in Europe Forum | | | |
| September 15, 2020Aktiedagen Digitalt | | | |
| September 9, 2020Interim Report May – July 2020 | | | |
| August 19, 2020Annual Report 2019 / 2020 | | | |
| July 30, 2020Analysguiden: Interview with Oasmia | | | |
| June 18, 2020Year-end Report 2019 / 2020 | | | |
| June 10, 2020Company Presentation Aktiespararna | | | |
| June 3, 2020Avanza Börsdag | | | |
| May 13, 2020Strategic Review Presentation | | | |
| March 27, 2020Interim Report May 2019 – January 2020 | | | |
| March 25, 2020Elevar deal | | | |
| February 14, 2020Oasmia appoints new CEO | | | |
| December 30, 2019Interim Report May – October 2019 | | | |
| September 26, 2019Interim Report May – July 2019 | | | |
| September 5, 2019Annual Report 2018 / 2019 | | | |
| June 28, 2019Year-end Report 2018 / 2019 | | | |
| March 1, 2019Interim report May 2018 – January 2019 | | | |
| November 20, 2018Interim report May – October 2018 | | | |
| August 31, 2018Interim report May – July 2018 | | | |
| August 24, 2018Annual Report 2017 / 2018 | | | |
| June 7, 2018Year-end Report May 2017 – April 2018 | | | |
| March 2, 2018Interim report May 2017 – January 2018 | | | |
| December 1, 2017Interim report May – October 2017 | | | |
| October 31, 2017US Interim report May – October 2016 | | | |
| September 1, 2017Interim Report May – July 2017 | | | |
| August 24, 2017Annual Report 2016 / 2017 | | | |
| August 2, 2017Registration statement on form F3 | | | |
| June 8, 2017Year-end Report May 2016 – April 2017 | | | |
| April 30, 201720-F Annual Report 2016-05-01 – 2017-04-30 | | | |
| March 2, 2017Interim Report May 2016 – January 2017 | | | |
| December 1, 2016US Interim report May – October 2016 | | | |
| December 1, 2016Interim Report May – October 2016 | | | |
| September 1, 2016Interim Report May 2016 – July 2016 | | | |
| August 25, 2016Annual Report 2015 / 2016 | | | |
| July 29, 2016Updated Registration Statement on Form F1 | | | |
| July 8, 2016Updated Registration Statement on Form F1 | | | |
| July 1, 2016Registration statement and Prospectus on Form F1 | | | |
| July 1, 2016US Interim Report May 2016 – July 2016 | | | |
| June 2, 2016Year-end Report May 2015 – April 2016 | | | |
| April 30, 201620-F Annual Report 2015-05-01 – 2016-04-30 | | | |
| April 1, 2016US Year-end Report May 2015 – April 2016 | | | |
| March 2, 2016Interim Report May 2015 – January 2016 | | | |
| January 1, 2016US Interim Report May 2015 – January 2016 | | | |
| December 2, 2015Interim Report May – October 2015 | | | |
| December 2, 2015US Interim Report May – October 2015 | | | |
| October 1, 2015US Interim Report May – October 2015 | | | |
| September 2, 2015Interim Report May – July 2015 | | | |
| August 20, 2015Annual Report 2014 / 2015 | | | |
| July 7, 2015Updated Registration Statement and Prospectus on Form F1 | | | |
| March 4, 2015Interim Report May 2014 – January 2015 | | | |
| December 3, 2014Interim Report May – October 2014 | | | |
| November 1, 2014Prospectus new share issue November 2014 | | | |
| September 4, 2014Interim Report May-July 2014 | | | |
| August 21, 2014Annual Report 2013 / 2014 | | | |
| June 5, 2014Year-end Report May 2013 – April 2014 | | | |
| March 6, 2014Interim Report May 2013 – January 2014 | | | |
| December 5, 2013Interim Report May – October 2013 | | | |
| September 6, 2013Interim Report May – July 2013 | | | |
| March 1, 2013Interim Report May 2012 – January 2013 | | | |
| December 6, 2012Interim Report May-October 2012 | | | |
| October 25, 2012New share issue Prospectus 2012-10-25 | | | |
| September 6, 2012Interim Report May-July 2012 | | | |
| August 23, 2012Annual Report 2011 / 2012 | | | |
| June 14, 2012Year-end Report May 2011-April 2012 | | | |
| March 8, 2012Interim Report May 2011 – January 2012 | | | |
| December 8, 2011Interim Report May – October 2011 | | | |
| November 1, 2011New share issue Prospectus 2010-11-01 | | | |
| September 8, 2011Interim Report May – July 2011 | | | |
| August 25, 2011Annual Report 2010 / 2011 | | | |
| June 10, 2011Year-end Report May 2010 – April 2011 | | | |
| March 9, 2011Interim Report May 2010 – January 2011 | | | |
| December 9, 2010Interim Report May-October 2010 | | | |
| September 9, 2010Interim Report May – July 2010 | | | |
| August 26, 2010Annual Report 2009 / 2010 | | | |
| June 10, 2010Year-end Report May 2009 – April 2010 | | | |
| June 6, 2010Listing Prospectus OMX 2010-06-17 | | | |
| December 10, 2009Interim Report May 2009-October 2009 | | | |
| September 17, 2009Oasmia Listing Prospectus 2007-09-17 | | | |
| September 10, 2009Interim report May 2009 – July 2009 | | | |
| August 28, 2009Annual Report 2008 / 2009 | | | |
| March 19, 2009Interim report May 2008 – January 2009 | | | |
| December 10, 2008Interim Report May 2008 – October 2008 | | | |
| December 10, 2008Interim Report May 2008 – October 2008 | | | |
| September 16, 2008Interim Report May – July 2008 | | | |
| September 16, 2008Interim Report May – July 2008 | | | |
| August 29, 2008Annual Report 2007 / 2008 | | | |
| June 16, 2008Year-end Report 2007-05-01 – 2008-04-30 | | | |
| June 16, 2008Year-end Report 2007-05-01 – 2008-04-30 | | | |
| March 14, 2008Interim Report May 2007 – January 2008 | | | |
| December 14, 2007Interim Report May – October 2007 | | | |
| September 10, 2007Communiqué from Annual General Meeting 2007-09-10 | | | |
| June 15, 2007Year-end Report 2006-05-01 – 2007-04-30 | | | |
| December 10, 2006Interim Report May – October 2006 | | | |
| August 14, 2006Annual Report 2005 / 2006 | | | |
| September 27, 2005Annual Report 2004 / 2005 | | | |
| December 1, 2023Swiss Nordic Bio | | | |
